Bionano Genomics (BNGO) Invested Capital (2017 - 2025)

Bionano Genomics has reported Invested Capital for 8 years, with the latest figure at $3.7 million in Q3 2025.

• Quarterly Invested Capital fell 1.78% year-over-year to $3.7 million in Q3 2025, while the trailing twelve-month figure through Mar 2026 was $7.5 million (down 50.67% YoY) and the FY2024 annual result came in at $3.8 million, down 1.5% from the prior year.
• Invested Capital retreated to $3.7 million in Q3 2025 per BNGO's latest filing, from $3.8 million in the prior quarter.
• Over five years, Invested Capital peaked at $3.9 million in Q4 2021 and troughed at $3.7 million in Q3 2025.
• A 5-year average of $3.9 million and a median of $3.9 million in 2023 frame the typical range for Invested Capital.
• The sharpest annual moves came in 2022 and 2025: Invested Capital decreased 0.94% in 2022, then retreated 1.78% in 2025.
• Over 5 years, Invested Capital stood at $3.9 million in 2021, then slipped by 0.94% to $3.9 million in 2022, then decreased by 1.2% to $3.9 million in 2023, then declined by 1.5% to $3.8 million in 2024, then slipped by 1.4% to $3.7 million in 2025.
• According to Business Quant data, Invested Capital over the past three periods registered $3.7 million, $3.8 million, and $3.8 million for Q3 2025, Q2 2025, and Q1 2025 respectively.